Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
10/2013
10/30/2013CN103380116A 6-(2-aminophenyl)picolinates and their use as herbicides
10/30/2013CN103380115A Sulfur derivatives as chemokine receptor modulators
10/30/2013CN103380114A Heterocyclic resorcinol derivatives, preparation of same and cosmetic uses thereof
10/30/2013CN103374124A Preparation method and application of polymer-loaded trialkyl organic sulfenyl tin
10/30/2013CN103373986A Crizotinib prodrug, as well as preparation and application thereof
10/30/2013CN103373958A Preparation method of 5-ethylpyridine-2,3-diethyl diformate
10/30/2013CN103373957A Chelate with functions of protecting nerve cells
10/30/2013CN103373928A Compound for organic light-emitting diode, organic light-emitting diode including the same and flat panel display device
10/30/2013CN102372663B Pyridyl indenofluorene compound and application thereof
10/30/2013CN102225896B Ether derivatives of rhein and their therapeutic use
10/30/2013CN102199121B 4-(4-(3-trifluoro methyl) benzamido phenoxyl)-2-(methyl carbamyl) pyridine salt, its preparation method and application
10/30/2013CN101948886B Pesticide residue degradation agent, vitamin PP homologue and vitamin B derivative
10/30/2013CN101906056B Cycloalkane amine compound as M2 inhibitor and application thereof
10/30/2013CN101511805B Carbonylated (aza) cyclohexanes as dopamine D3 receptor ligands
10/29/2013US8569543 CCR9 inhibitors and methods of use thereof
10/29/2013US8569502 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids
10/29/2013US8569336 Compounds for the treatment of inflammatory disorders
10/29/2013US8569317 Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives
10/29/2013CA2690229C Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
10/24/2013WO2013158422A1 Heterocyclic compounds for controlling invertebrate pests
10/24/2013WO2013157889A1 Use of a novel aminopyridine derivative to prevent or treat cancer
10/24/2013WO2013157622A1 Hiv replication inhibitor
10/24/2013WO2013157540A1 Nitrogen-containing heterocyclic compound or salt thereof
10/24/2013WO2013157495A1 Organic electroluminescence element and production method for organic electroluminescence element
10/24/2013WO2013156154A1 Substituted 6-amino-nicotinamides bearing an oh-containing group as kcnq2/3 modulators
10/24/2013US20130281705 Compounds for the treatment of metabolic disorders
10/24/2013US20130281703 Small Molecules Modulator of Epigenetic Regulation and Their Therapeutic Applications
10/24/2013US20130281700 Palladium catalyst, method for its preparation and its use
10/24/2013US20130281664 Novel ruthenium complexes and their uses in processes for formation and/or hydrogenation of esters, amides and derivatives thereof
10/24/2013US20130281494 Polymorphs of n-(6-(4-chlorophenoxy)hexyl)-n'-cyano-n"-(4-pyridyl)guanidine, and preparation thereof and use thereof
10/24/2013US20130281469 Thioacetate compounds, compositions and methods of use
10/24/2013US20130281443 Inhibitors of focal adhesion kinase
10/24/2013US20130281428 Pyridone Derivatives
10/24/2013US20130281366 Heterocyclic compounds suitable for the treatment of dyslipidemia
10/23/2013EP2651897A1 Process for depigmenting keratin materials using thiopyridinone compounds
10/23/2013EP2651896A1 Neprilysin inhibitors
10/23/2013EP2651895A1 Oxime compounds as hdl-cholesterol raising agents
10/23/2013EP2651894A1 Thiosemicarbazone compounds and use in the treatment of cancer
10/23/2013EP2651893A1 Sulfur derivatives as chemokine receptor modulators
10/23/2013EP2651856A1 A new palladium catalyst, method for its preparation and its use
10/23/2013EP2651816A1 Compositions containing hydrogen peroxide or substances releasing hydrogen peroxide
10/23/2013CN103370308A Thiosemicarbazone compounds and use in the treatment of cancer
10/23/2013CN103370302A Process for the direct amination of alcohols using ammonia to form primary amines by means of a Xantphos catalyst system
10/23/2013CN103360364A Synthetic method of aromatic cyclo-ethanol
10/23/2013CN103360331A Novel lamotrigine pharmaceutical co-crystal and preparation method thereof
10/23/2013CN103360308A 1,4-dyhydroxy-6-methyl-2-pyridine ketone compound, and preparation method and use thereof
10/23/2013CN103360307A Preparation method of 5-chloro-2,4-dihydroxypyridine
10/23/2013CN103360306A Method for synthesizing 4-chloro-pyridine
10/23/2013CN103360305A Substituted aryl piperazine aralkyl ketone derivative and application of derivative in preparing analgesic
10/23/2013CN103360304A Processing production apparatus for 2-methylpyridine
10/23/2013CN103360303A Compound with pyridine as nucleus, preparation method and applications
10/23/2013CN103360269A Preparation method of 3-chloro-2-aminophenol
10/23/2013CN103356636A Theramutein调节剂 Theramutein moderator
10/23/2013CN102702092B Eutectic of two curcumin organic medicaments and preparation method thereof
10/23/2013CN102557135B Nanometer chromium vanadate as well as preparation method and application thereof
10/23/2013CN102372532B Palladium-catalyzed ortho-orientation nitrification method of aza calixarene compounds
10/23/2013CN102276594B Iloperidone medicinal cocrystal and preparation method thereof
10/23/2013CN102146007B Method for preparing secondary amine and tertiary amine
10/23/2013CN102036957B Compound comprising phenyl pyridine units
10/23/2013CN101796026B Guanidine-containing compounds useful as muscarinic receptor antagonists
10/22/2013US8563763 Composition, synthesis and use of isonitriles
10/22/2013US8563736 Amide derivatives, process for preparation thereof and use thereof as insecticide
10/22/2013US8563735 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
10/22/2013US8563714 Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonists
10/22/2013US8563583 Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists
10/22/2013US8562945 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
10/22/2013CA2587545C Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions
10/17/2013WO2013154080A1 Aryloxyurea compound and pest control agent
10/17/2013US20130274478 Polymorphs of sorafenib acid addition salts
10/17/2013US20130274272 Methyl/difluorophenyl-methoxy substituted pyridinone-pyridinyl compounds, methyl-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds, and methyl-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds
10/17/2013US20130274263 Tubulin inhibitors
10/17/2013US20130274240 Fluorene compound and pharmaceutical use thereof
10/17/2013US20130273034 Novel compounds and compositions for the inhibition of nampt
10/17/2013US20130273004 Substituted alkylamine derivatives and methods of use
10/16/2013EP2650283A1 Process for producing substituted methylamine compound and triazine derivative
10/16/2013EP2650282A1 Process for producing substituted methylamine compound and triazine derivative
10/16/2013EP2650276A1 Method for producing -fluoroalcohol
10/16/2013EP2650274A2 A thionation process and a thionating agent
10/16/2013EP2649050A1 Compounds
10/16/2013EP2649049A2 Produce to produce etoricoxib
10/16/2013EP2649040A1 Process for homogeneously catalyzed, highly selective direct amination of primary alcohols with ammonia to primary amines with a high volume ratio of liquid phase to gas phase and/or high pressures
10/16/2013EP2648714A2 Lysophosphatidic acid receptor antagonists and uses thereof
10/16/2013EP2648710A1 Pyridonyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
10/16/2013EP2648510A1 Methods for the preparation of charged crosslinkers
10/16/2013EP2325160B1 Metal complex and manufacturing method therefor
10/16/2013CN103351390A Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
10/16/2013CN103351334A Synthetic method for chelation-type precipitator and use method
10/16/2013CN103351333A Aryl pyridine derivative compound and preparation method thereof
10/16/2013CN103351332A Conjugate extension carboxyl dipyridyl ligand and synthetic method and application for ruthenium dye thereof
10/16/2013CN103351331A Marine natural product Echinoclathrine A preparation method
10/16/2013CN103351330A Processing device for producing 2-picoline
10/16/2013CN103351270A Method for catalyzing Knoevenagel condensation reaction by using function ion liquid
10/16/2013CN102731370B Preparation method of ionic liquid and synthesizing method of biphenyl compounds by applying palladium carbon catalysis in ionic liquid
10/16/2013CN102532012B Method for preparing 2-substituted-5-((1-alkyl sulfenyl) alkyl) pyridine
10/16/2013CN101747320B Dialdehyde-built nitrogen or oxygen-containing heterocyclic compound with insect-killing activity and preparation method
10/15/2013US8558001 Compounds for the treatment of addiction
10/15/2013US8557933 Methods for preparation of pyridylamines and their use in oligomerization reactions
10/15/2013US8557853 Aryl fluoroethyl ureas acting as alpha 2 adrenergic agents
10/15/2013US8557852 Methods of using crystalline forms of a salt of a factor Xa inhibitor
10/15/2013US8557825 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 633